In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
410 News Items found
A researcher pipettes in the lab
MSK Research Highlights, June 25, 2024

New MSK research helped develop a machine-learning tool to help find cancer cells that remain after surgery; led to FDA approval for CAR T cell therapy against mantle cell lymphoma; tested a liquid biopsy approach that shows promise in detecting lung cancer; found checkpoint inhibitors were effective against endometrial and ovarian cancers with DNA-repair deficiency; and shed new light on mTOR's role in metabolic enzyme degradation.
MSK medical oncologist Michael Morris
Researching New Treatments for Neuroendocrine Prostate Cancer (NEPC)

Learn about MSK's specialty in treating neuroendocrine cancers.
a lab coat hangs in an MSK lab
MSK Research Highlights, November 6, 2024

New MSK research marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health; uncovers how changes to “helper” proteins drive cancer cell survival; develops a new model for investigating lung cancer metastasis; and uses AI to improve outcome predictions in sarcoma.
Dr. Bob Li
Medical Oncologist Bob Li Featured in the Presidential Symposium at the 2020 World Conference on Lung Cancer

Dr. Bob Li will present registrational phase II data from the first-ever trial of a drug that blocks cancer gene KRAS.
Pictured: Cancer cell on blood vessel
In the Lab
Holding On and Hiding Out: How Cancer Cells Spread to the Brain and Thrive

Researchers have gained new understanding of how tumors metastasize by studying the behavior of exceptional breast and lung cancer cells that are capable of entering the brain and surviving there.
Joey Laurore and Dr. Bob Li
Feature
For Some People with Cancer, a Simple Blood Test Can Be a Lifesaver

He was given a wrong diagnosis. A blood test changed his life.
Blue cells containing small red and green dots on a black background
In the Lab
Scientists Pinpoint a New Cause of Resistance to EGFR-Targeting Drugs

Multiple copies of a gene called YES1 appear to be responsible for certain precision drugs losing their effectiveness.
Physician-scientist Piro Lito
In the Lab
Researchers Uncover New Findings about KRAS, an Important Protein in Cancer

Researchers have taken a closer look at what a protein called KRAS does in normal cells and how certain KRAS mutations lead to for cancer growth.
Illustration of a female doctor touching a strand of DNA
In the Clinic
New MSK Initiative Focuses on the Early Detection and Prevention of Cancer

Because cancer is more treatable when it’s caught early, MSK’s new Precision Interception and Prevention initiative focuses on early detection.
MSK President Craig Thompson
New Collaboration Will Accelerate US-China Clinical Trials

In a first-of-its-kind collaboration, MSK has joined forces with the Chinese Thoracic Oncology Group in an effort to establish a program of clinical trials that are open to patients from both the United States and China.